Tobi

Background

For the management of cystic fibrosis patients with chronic pulmonary P. aeruginosa infections (the most common type of bacterial lung infection in people with CF).

Therapeutic Area

Anti-Infective (Cystic Fibrosis)

Acquisition Date

Jan 1999

Marketer